BioAssets Development Corporation (aka BDC) (Acquired)

Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniatio....

Learn More

Get a Demo and See the Full Profile

Get a demo today to see profiles of BioAssets Development Corporation (aka BDC) (Acquired) plus 5896 other startups.

Learn More

Learn More About BioAssets Development Corporation (aka BDC) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More